Literature DB >> 6286891

Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma.

R D McComb, T R Jones, S V Pizzo, D D Bigner.   

Abstract

The sarcomatous components of most glioma-sarcomas are thought to arise from the neoplastic transformation of hyperplastic endothelial and adventitial vascular cells in a preexisting glioblastoma multiforme. The expression of factor VIII/von Willebrand factor (FVIII/vWF), a marker for endothelial cells, and of glial fibrillary acidic protein (GFAP), a marker for glial cells, was examined in 10 glioblastomas and seven mixed glioma-sarcomas using the peroxidase-antiperoxidase immunohistochemical technique. Hyperplasia of small blood vessels was observed in all 10 glioblastomas; in five, the vascular proliferation had resulted in the formation of prominent glomeruloid structures. FVIII/vWF was detected in the endothelial cells in these vascular structures, but not in the adventitial cells. In the mixed glioma-sarcomas. FVIII/vWF was detected only in endothelial cells; there was no staining for FVIII/vWF in the neoplastic mesenchymal cells. The gliomatous components of the mixed tumors stained intensely for GFAP. These observations indicate that both endothelial and nonendothelial cell types contribute to the small vessel hyperplasia in glioblastomas, and that the sarcomatous components of mixed glioma-sarcomas are derived from either non-endothelial cells or endothelial cells that have undergone antigenic loss following transformation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286891

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  24 in total

1.  Sarcomatous proliferation of the vasculature in a subependymoma: a follow-up study of sarcomatous dedifferentiation.

Authors:  D N Louis; E T Hedley-Whyte; R L Martuza
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Authors:  R M Tuder; B Groves; D B Badesch; N F Voelkel
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

3.  Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.

Authors:  C L Gladson; D A Cheresh
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Vascular response to irradiation in malignant gliomas.

Authors:  D Schiffer; A Chiò; M T Giordana; A Mauro; A Migheli; R Soffietti; M C Vigliani
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

5.  Multifocal spinal angiosarcoma after chordotomy.

Authors:  W Kristoferitsch; K Jellinger
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

6.  Multi-focal gliosarcoma: a case report and review of the literature.

Authors:  E E Pakos; A C Goussia; V P Zina; E J Pitouli; P G Tsekeris
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

7.  Medulloblastomas in childhood: histological factors influencing patients' outcome.

Authors:  K Taomoto; T Tomita; A J Raimondi; J E Leestma
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

8.  Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies.

Authors:  F Slowik; K Jellinger; L Gaszó; J Fischer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

9.  Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material.

Authors:  P Wesseling; J J Vandersteenhoven; B T Downey; D J Ruiter; P C Burger
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 10.  Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.

Authors:  Seunggu J Han; Isaac Yang; Tarik Tihan; Michael D Prados; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-07-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.